Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19
Teicoplanin is a glycopeptide antibiotic effective against several bacterial infections, has exhibited promising therapeutic efficiency against COVID-19 in vitro<i>,</i> and the rationale for its use in COVID-19 is yet to be recognized. Hence, in this study a number of molecular modeling...
Saved in:
Main Author: | Faizul Azam (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Teicoplanin-A New Use for an Old Drug in the COVID-19 Era?
by: Vladimir Vimberg
Published: (2021) -
Clinical practice and costs of treating catheter-related infections with teicoplanin or vancomycin
by: Simoens S, et al.
Published: (2006) -
The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin
by: Ilona Bereczki, et al.
Published: (2022) -
Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
by: Matsumoto K, et al.
Published: (2016) -
Drug Elucidation: Invertebrate Genetics Sheds New Light on the Molecular Targets of CNS Drugs
by: Donard S. Dwyer, et al.
Published: (2014)